sefulness of fungal biomarkers for diagnosis and therapy monitoring in patients with candidemia

• Conditions: B37.7; Candidal sepsis

• Registration Number: DRKS00005135
• Lead Sponsor: niklinik Freiburg und Erlangen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-07-24
• Study Completion: 2021-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 131

Inclusion Criteria

Culture-proven candidemia

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensitivity/Specificity of the antigen assays

Secondary Outcome Measures

Name	Time	Method
Earliest time point of positive index test